Yuriko Nagane

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

James F. Howard, Saskia Bresch, Angela Genge et al. · The Lancet Neurology · 2023 · 250 citations

Medicine, Pharmacotherapy, Pain Management +2

Reduction with age in methylcytosine in the promoter region −224∼−101 of the amyloid precursor protein gene in autopsy human cortex

Hideo Tohgi, Kimiaki Utsugisawa, Yuriko Nagane et al. · Molecular Brain Research · 1999 · 180 citations

Life Sciences, Genetics, Neuroscience +15

International clinimetric evaluation of the MG‐QOL15, resulting in slight revision and subsequent validation of the MG‐QOL15r

Ted M. Burns, Reza Sadjadi, Kimiaki Utsugisawa et al. · Muscle & Nerve · 2016 · 156 citations

Medicine, Biostatistics, Health Assessment +15

Efficacy of Low-Dose FK506 in the Treatment of Myasthenia gravis – A Randomized Pilot Study

Yuriko Nagane, Kimiaki Utsugisawa, Daiji Obara et al. · European Neurology · 2005 · 108 citations

Medicine, Pharmacology, Pharmacotherapy +12